Why perimenopause hits harder than most women expect

Recovery takes longer than it used to. Joints that were fine last year now ache after a workout. Sleep feels lighter, concentration shorter, and mood carries a chemical edge that stress alone cannot quite explain. For many women in their forties, these shifts arrive without a clear label — quietly absorbed into the background noise of a busy life, attributed to overwork or simply getting older.

What is actually happening is more specific, and more tractable, than that.

Oestrogen is not merely a reproductive signal. It is one of the body's most powerful systemic regulators — present in bone, muscle, tendon, brain, and gut — and during perimenopause it does not fade gracefully. It fluctuates, surges, and drops erratically, sometimes from around age 35, long before the final menstrual period. That volatility creates a chemistry storm that disrupts repair processes across virtually every tissue at once.

In Regeneration by Design, Professor Paul Lee places hormones squarely within the Chemistry pillar — the body's internal environment that determines how well it can rebuild itself. Understanding what oestrogen actually does to repair biology is the first step in treating this as a design problem rather than an inevitability.

Oestrogen as a whole-body repair signal

Think of oestrogen as a broadcast signal rather than a local message. The receptors that receive it — ERα and ERβ — are distributed across bone, skeletal muscle, tendon, skin, gut lining, and brain tissue. This is not a reproductive quirk; it is a fundamental feature of human repair biology. A hormone with that reach is not behaving like a local anaesthetic; it behaves like a network-wide protocol.

The receptor distribution matters because it explains something that otherwise seems medically implausible: a single hormone's disruption can simultaneously cause joint pain, slower muscle recovery, altered gut motility, thinning skin, and cognitive fog. These are not separate complaints requiring separate explanations. They share a common upstream cause.

At the tissue level, oestrogen performs distinct but related functions across each system. In bone, it limits the remodelling cycle that would otherwise run continuously towards net loss. In skeletal muscle, it supports satellite cell activity — the repair mechanism that rebuilds fibres after effort. In tendons, it drives collagen type I deposition and promotes the migration and proliferation of tenocytes, the cells responsible for structural renewal. In the brain, it sustains neurotrophic signalling that underpins memory consolidation and mood regulation.

Perimenopause, viewed through this lens, is not a localised hormonal event. It is a systemic chemistry disruption — the Chemistry pillar under strain. What that looks like specifically in bone and connective tissue, and then in the brain, is where the most precise evidence now sits.

What happens to bone, tendon, and collagen

Bone is where the timeline becomes starkly visible. Rapid loss is not spread evenly across the decades; it concentrates in roughly a three-year window bracketing the final menstrual period, and it is measurable before that window even opens. Each halving of circulating estradiol is associated with a 10% greater risk of significant lumbar spine bone loss — which means oestrogen levels can serve as a prospective signal, not just a retrospective explanation.

The character of that loss matters too. Contrary to how bone density is often discussed, the predominant loss at menopause is cortical rather than trabecular — the dense outer shell of bone becomes more porous, a change that raises fracture vulnerability in ways that standard density scans alone can underestimate.

In tendons, the mechanism is equally direct. ERβ — one of the two main oestrogen receptor subtypes — is required for correct collagen type I deposition during healing. Remove the receptor and the extracellular matrix rebuilds incorrectly, with inferior biomechanical properties. The signalling pathway responsible runs through the IRF5-CCL3 inflammatory axis: without ERβ, this axis tips towards a sustained inflammatory environment that disrupts the structural repair sequence. Separately, oestrogen receptor signalling via IGF1R and MAPK pathways drives tenocyte migration and proliferation. When receptor activity falls, those repair cascades simply do not fire.

The practical consequence is the joint pain and slower recovery that Practical Regeneration places explicitly within the Chemistry pillar. The difficulty is that reaching for NSAIDs — a natural response to that pain — adds its own chemical burden. Anti-inflammatory medications can stress the gut lining and worsen bloating that is already more common as hormone levels fall, compounding one Chemistry disruption with another rather than addressing the underlying repair deficit. Managing symptoms symptomatically, in other words, can quietly deepen the problem the symptoms are pointing to.

The neuroinflammation effect: brain fog is biochemistry

The word-finding pause mid-sentence. The afternoon fog that no amount of coffee resolves. The mood dip that arrives without an obvious cause. Women often attribute these experiences to stress or overload — but a 2026 longitudinal study of 150 perimenopausal women tracked over 12 months tells a more precise story.

As estradiol fell, IL-6 and TNF-α — two proinflammatory cytokines — rose. BDNF, a protein that functions as the brain's primary repair and maintenance signal (it supports the formation and survival of neurons, and is essential to memory consolidation), declined in parallel. MRI imaging revealed a 2.8% reduction in bilateral hippocampal volume over the year — a structure central to memory and spatial reasoning. Verbal, visuospatial, and working memory all deteriorated measurably. Crucially, the inflammatory and neurotrophic markers together accounted for 38% of the statistical link between estradiol decline and memory impairment. That figure matters because it points to mechanism, not coincidence: the brain is not responding to a difficult life stage; it is losing a biochemical signal it depends on for repair.

Oestrogen normally provides anti-inflammatory buffering and sustains neurotrophic activity in the brain. As its levels become erratic during perimenopause, that buffer thins. Brain fog and mood instability are, in this framing, Chemistry pillar disruptions — the same category of problem as the joint pain and collagen deficits covered above, just expressed through neural tissue.

And the disruption does not stay confined to the brain. The gut and sleep systems are pulled into the same cycle — which is where the Biology pillar enters the picture.

The gut-sleep cycle that amplifies the storm

The estrobolome is the community of gut bacteria responsible for deconjugating and recycling oestrogen back into circulation — and it is itself regulated by oestrogen. When circulating levels fall, microbial diversity falls with them. A less diverse estrobolome recirculates less oestrogen, which further reduces circulating levels, which further impairs the microbiome. The loop closes on itself: a self-reinforcing cycle that amplifies the original Chemistry disruption rather than correcting it.

Sleep is where this cycle becomes most damaging to repair. Hot flushes, night waking, and anxiety — perimenopause hallmarks — fragment the sleep architecture the body relies on as its primary repair window. Tissue regenerates, inflammatory signals are cleared, and memory is consolidated during sleep; lose that window and every other Chemistry deficit covered in this article compounds. A 2026 systematic review of 20 RCTs involving approximately 2,700 perimenopausal women found that structured CBT-based interventions and mind-body practices — yoga, Pilates, tai chi — consistently improved sleep quality and mental health markers. The window is not irrecoverable, but restoring it requires deliberate design rather than hoping circumstances improve.

This is precisely where Regeneration by Design insists on systemic thinking. The Chemistry pillar — hormone balance, inflammation, the gut environment — does not fail in isolation. It pulls the Biology pillar (gut ecosystem, immune regulation) and the Time pillar (repair windows, early action) into the same descent. Addressing one without the others is like patching a leak while the pressure keeps rising.

Designing the chemistry response

Knowing the mechanism changes what you reach for. The biochemical failures described above — cortical bone loss, ERβ-dependent collagen disruption in tendon, BDNF decline — each correspond to a specific lever in the Regeneration by Design response.

Practical Regeneration is explicit on the foundations: strength training loads bone and drives the remodelling that oestrogen would otherwise regulate, preserves muscle mass, and reduces systemic inflammatory markers. Protein at 1.2–1.6 g/kg bodyweight and adequate healthy fats supply the substrate for tissue repair. These are Chemistry design choices, not compensatory measures.

HRT merits more than a footnote here. Restoring circulating estradiol addresses the upstream signal whose loss drives cortical bone porosity and tendon repair failure described in earlier sections. Evidence suggests it can arrest or slow the rapid bone loss concentrated in the perimenopausal transition, and oestrogen receptor activity in connective tissue — the same signalling required for correct collagen deposition and tenocyte repair — may be partly restored. For many women it represents a legitimate first-line option, not something to reach for only after years of symptom management alone. That conversation belongs with a qualified practitioner, but it should be an informed one: arriving with the mechanisms understood, not merely a list of symptoms.

The Regen PhD 32-biomarker panel — part of Professor Paul Lee's monitoring framework and spanning inflammation, energy, and recovery signals across six biological systems — provides a baseline against which these Chemistry shifts can be tracked rather than absorbed passively. Monitoring turns a reactive experience into a designed one.

The most concrete step available this week: begin structured strength training and set a protein target of at least 1.2 g/kg. Every other part of the response — HRT discussion, biomarker tracking, gut and sleep strategy — lands on firmer ground when built on a body that is already being loaded and fuelled.

1. [1] Estrogen receptor. https://en.wikipedia.org/?curid=1581134 https://en.wikipedia.org/?curid=1581134
2. [2] The absence of oestrogen receptor beta disturbs collagen I type deposition during Achilles tendon healing by regulating the IRF5‐CCL3 axis. (2020). https://doi.org/10.1111/jcmm.15592 https://doi.org/10.1111/jcmm.15592
3. [3] Can oestrogen influence skeletal muscle damage, inflammation, and repair?. (2005). https://doi.org/10.1136/bjsm.2005.016881 https://doi.org/10.1136/bjsm.2005.016881
4. [4] Ginsenoside Rg1 enhances the healing of injured tendon in achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor. (2021). https://doi.org/10.1016/j.jgr.2021.08.005 https://doi.org/10.1016/j.jgr.2021.08.005
5. [5] Estradiol and follicle stimulating hormone as predictors of onset of menopause transition-related bone loss in pre- and perimenopausal women. (2019). https://doi.org/10.1002/jbmr.3856 https://doi.org/10.1002/jbmr.3856
6. [6] Inflammaging. https://en.wikipedia.org/?curid=59830296 https://en.wikipedia.org/?curid=59830296
7. [7] Estradiol reduction during perimenopause is associated with lower BDNF, elevated inflammation, hippocampal loss, and cognitive decline. (2026). https://doi.org/10.1016/j.exger.2026.113219 https://doi.org/10.1016/j.exger.2026.113219
8. [8] Gut-Brain Communication in Menopause: Insights into Neuroendocrine and Microbiome Interactions. (2026). https://doi.org/10.1017/S0029665126102201 https://doi.org/10.1017/S0029665126102201
9. [9] Hormones and bone loss across the menopause transition. (2021). https://doi.org/10.1016/bs.vh.2020.12.016 https://doi.org/10.1016/bs.vh.2020.12.016
10. [10] Menopause‐Related Appendicular Bone Loss is Mainly Cortical and Results in Increased Cortical Porosity. (2018). https://doi.org/10.1002/jbmr.3333 https://doi.org/10.1002/jbmr.3333
11. [11] Menopause is associated with bone loss, particularly at the distal radius, in black South African women. (2022). https://doi.org/10.1016/j.bone.2022.116543 https://doi.org/10.1016/j.bone.2022.116543
12. [12] More Than Oestrogen: A Systematic Review of Holistic Strategies for Mental Health Symptoms in Perimenopausal Women. (2026). https://doi.org/10.1192/bjo.2026.11232 https://doi.org/10.1192/bjo.2026.11232